Equasens Acquires 80% of Erevo to Accelerate Digital Training Strategy
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 05 2026
0mins
Should l Buy EQS?
Source: Globenewswire
- Acquisition of Erevo: Equasens has acquired an 80% controlling stake in Erevo, expected to generate €7.4 million in revenue by 2025, significantly enhancing its market position in healthcare professional training.
- Training Product Expansion: This acquisition integrates Erevo's online courses with Equasens' existing services, improving training quality and addressing the healthcare industry's demand for continuous education, which is anticipated to boost customer satisfaction and market share.
- Synergies Realized: Erevo's digital training solutions complement Equasens' hardware and software offerings, expected to create substantial operational and marketing synergies that support the company's growth in the rapidly evolving healthcare education market.
- Future Development Potential: By leveraging Erevo's expertise, Equasens plans to develop new AI-driven features to enhance educational effectiveness, ensuring its leadership position in the healthcare training sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EQS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EQS
About EQS
Equus Total Return, Inc. (the Fund) is a closed-end management investment company. The Fund's investment objective is to maximize the total return to the Company's stockholders in the form of current investment income and long-term capital gains by investing in the debt and equity securities of small and middle market capitalization companies that are generally not publicly traded at the time of its investment. It seeks to invest in companies pursuing growth through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations. The Fund's income-producing investments includes debt securities, including subordinate debt, debt convertible into common or preferred stock, or debt combined with warrants and common and preferred stock. It invests in the portfolio company, Equus Energy, LLC, which makes investments in companies in the energy sector, with particular emphasis on income-producing oil and gas properties.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Equasens Acquires 80% of Erevo to Accelerate Digital Training Strategy
- Acquisition of Erevo: Equasens has acquired an 80% controlling stake in Erevo, expected to generate €7.4 million in revenue by 2025, significantly enhancing its market position in healthcare professional training.
- Training Product Expansion: This acquisition integrates Erevo's online courses with Equasens' existing services, improving training quality and addressing the healthcare industry's demand for continuous education, which is anticipated to boost customer satisfaction and market share.
- Synergies Realized: Erevo's digital training solutions complement Equasens' hardware and software offerings, expected to create substantial operational and marketing synergies that support the company's growth in the rapidly evolving healthcare education market.
- Future Development Potential: By leveraging Erevo's expertise, Equasens plans to develop new AI-driven features to enhance educational effectiveness, ensuring its leadership position in the healthcare training sector.
See More
Equasens Announces Financial Calendar for FY 2026
- Financial Calendar Release: Equasens announces its financial calendar for FY 2026, with 2025 annual revenue set to be released on February 5, 2026, reflecting the company's commitment to transparency and aiming to bolster investor confidence.
- Earnings Report Schedule: The 2025 annual results will be published on March 30, 2026, followed by the Q1 2026 revenue report, which is expected to provide critical performance metrics that will help the market assess the company's future growth potential.
- Annual General Meeting Date: The company plans to hold its Annual General Meeting on June 25, 2026, aiming to enhance communication with shareholders and promote corporate governance and transparency.
- Commitment to Sustainable Development: As a leader in digital healthcare solutions, Equasens is dedicated to supporting healthcare professionals through regular financial disclosures, further solidifying its leadership position in the industry.
See More
EquipmentShare.com Inc. Launches ABS Transaction Rated by KBRA
- ABS Transaction Overview: KBRA assigns preliminary ratings to three classes of notes issued by OWN Equipment Fund III LLC, marking EquipmentShare.com Inc.'s fourth equipment rental ABS transaction as Equipment Manager, indicating its ongoing activity in the market.
- Funding Structure: The transaction's funding is secured through a lease agreement between EquipmentShare and the issuer, where EQS pays a variable lease payment based on customer rental fees, ensuring initial cash flow for noteholders.
- Partnership Dynamics: The other co-sponsor for this transaction is the newly formed OWN Tactical Equipment III LLC, managed by MidOcean Credit Fund Management LP, highlighting EquipmentShare's strategic partnership expansion in the equipment rental market.
- Market Impact: Through this ABS transaction, EquipmentShare not only enhances its financing capabilities but also solidifies its market position in the equipment rental industry, which is expected to positively influence its future business growth.
See More
Equus Total Return Reports $26.5M Net Assets, Share Value Drops to $1.90
- Net Asset Decline: As of September 30, 2025, Equus reported net assets of $26.5 million, a 16.5% decrease from $34.1 million on June 30, 2025, indicating a deterioration in financial health that may impact investor confidence.
- Decrease in Net Asset Value per Share: The net asset value per share fell from $2.51 on June 30, 2025, to $1.90, a 24.3% drop, suggesting increased market pressures that could lead to reduced shareholder returns.
- Loss on GEVI Investment: Equus saw the value of its investment in General Enterprise Ventures decrease from $10.6 million to $5.2 million during Q3, a 54.7% decline, reflecting adverse performance in high-risk investments that may affect future investment strategies.
- Stability in Morgan E&P: Despite a downturn in the oil and gas market, Equus maintained its investment value in Morgan E&P at $12.35 million, indicating stability in this sector that could support future growth opportunities.
See More
Equus Subsidiary, Morgan E&P, Secures $3 Million Term Loan to Advance Drilling and Work-Over Program in North Dakota's Williston Basin
Equus Total Return, Inc. Funding Announcement: Equus announced that its subsidiary, Morgan E&P, has secured a $3 million term loan to fund drilling operations in the Bakken Shale formation, aiming to enhance production and cash flow by developing existing non-producing wells.
Strategic Development Plans: The funding will allow Morgan to accelerate development opportunities in both operated and non-operated acreage, with expectations of increasing production volumes and strengthening Equus' energy portfolio strategy in one of North America's key oil-producing regions.
See More
Equus Total Return, Inc. Announces Intent to Regain Compliance with NYSE Listing Standards Following Price Deficiency Notice
Equus Total Return, Inc. Compliance Issue: The company received a notice from the NYSE for not meeting the minimum average closing price requirement of $1.00 for its common stock over a 30-day period, but this deficiency does not currently affect its listing or trading status.
Plans to Regain Compliance: Equus intends to notify the NYSE by May 25, 2025, of its plan to address the stock price deficiency, potentially through a reverse stock split, and has a six-month period to regain compliance with the NYSE's standards.
See More
Equasens Acquires 80% of Erevo to Accelerate Digital Training Strategy
- Acquisition of Erevo: Equasens has acquired an 80% controlling stake in Erevo, expected to generate €7.4 million in revenue by 2025, significantly enhancing its market position in healthcare professional training.
- Training Product Expansion: This acquisition integrates Erevo's online courses with Equasens' existing services, improving training quality and addressing the healthcare industry's demand for continuous education, which is anticipated to boost customer satisfaction and market share.
- Synergies Realized: Erevo's digital training solutions complement Equasens' hardware and software offerings, expected to create substantial operational and marketing synergies that support the company's growth in the rapidly evolving healthcare education market.
- Future Development Potential: By leveraging Erevo's expertise, Equasens plans to develop new AI-driven features to enhance educational effectiveness, ensuring its leadership position in the healthcare training sector.
See More
Equasens Announces Financial Calendar for FY 2026
- Financial Calendar Release: Equasens announces its financial calendar for FY 2026, with 2025 annual revenue set to be released on February 5, 2026, reflecting the company's commitment to transparency and aiming to bolster investor confidence.
- Earnings Report Schedule: The 2025 annual results will be published on March 30, 2026, followed by the Q1 2026 revenue report, which is expected to provide critical performance metrics that will help the market assess the company's future growth potential.
- Annual General Meeting Date: The company plans to hold its Annual General Meeting on June 25, 2026, aiming to enhance communication with shareholders and promote corporate governance and transparency.
- Commitment to Sustainable Development: As a leader in digital healthcare solutions, Equasens is dedicated to supporting healthcare professionals through regular financial disclosures, further solidifying its leadership position in the industry.
See More
EquipmentShare.com Inc. Launches ABS Transaction Rated by KBRA
- ABS Transaction Overview: KBRA assigns preliminary ratings to three classes of notes issued by OWN Equipment Fund III LLC, marking EquipmentShare.com Inc.'s fourth equipment rental ABS transaction as Equipment Manager, indicating its ongoing activity in the market.
- Funding Structure: The transaction's funding is secured through a lease agreement between EquipmentShare and the issuer, where EQS pays a variable lease payment based on customer rental fees, ensuring initial cash flow for noteholders.
- Partnership Dynamics: The other co-sponsor for this transaction is the newly formed OWN Tactical Equipment III LLC, managed by MidOcean Credit Fund Management LP, highlighting EquipmentShare's strategic partnership expansion in the equipment rental market.
- Market Impact: Through this ABS transaction, EquipmentShare not only enhances its financing capabilities but also solidifies its market position in the equipment rental industry, which is expected to positively influence its future business growth.
See More
Equus Total Return Reports $26.5M Net Assets, Share Value Drops to $1.90
- Net Asset Decline: As of September 30, 2025, Equus reported net assets of $26.5 million, a 16.5% decrease from $34.1 million on June 30, 2025, indicating a deterioration in financial health that may impact investor confidence.
- Decrease in Net Asset Value per Share: The net asset value per share fell from $2.51 on June 30, 2025, to $1.90, a 24.3% drop, suggesting increased market pressures that could lead to reduced shareholder returns.
- Loss on GEVI Investment: Equus saw the value of its investment in General Enterprise Ventures decrease from $10.6 million to $5.2 million during Q3, a 54.7% decline, reflecting adverse performance in high-risk investments that may affect future investment strategies.
- Stability in Morgan E&P: Despite a downturn in the oil and gas market, Equus maintained its investment value in Morgan E&P at $12.35 million, indicating stability in this sector that could support future growth opportunities.
See More
Equus Subsidiary, Morgan E&P, Secures $3 Million Term Loan to Advance Drilling and Work-Over Program in North Dakota's Williston Basin
Equus Total Return, Inc. Funding Announcement: Equus announced that its subsidiary, Morgan E&P, has secured a $3 million term loan to fund drilling operations in the Bakken Shale formation, aiming to enhance production and cash flow by developing existing non-producing wells.
Strategic Development Plans: The funding will allow Morgan to accelerate development opportunities in both operated and non-operated acreage, with expectations of increasing production volumes and strengthening Equus' energy portfolio strategy in one of North America's key oil-producing regions.
See More
Equus Total Return, Inc. Announces Intent to Regain Compliance with NYSE Listing Standards Following Price Deficiency Notice
Equus Total Return, Inc. Compliance Issue: The company received a notice from the NYSE for not meeting the minimum average closing price requirement of $1.00 for its common stock over a 30-day period, but this deficiency does not currently affect its listing or trading status.
Plans to Regain Compliance: Equus intends to notify the NYSE by May 25, 2025, of its plan to address the stock price deficiency, potentially through a reverse stock split, and has a six-month period to regain compliance with the NYSE's standards.
See More
